Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
127828-22-2
139115-91-6
165963-71-3
108466-89-3
462100-06-7
1076199-21-7
18418-72-9 | BIS(TRIETHOXYSILYL)METHANE | AA00ACCI | MFCD00270971
196935-03-2 | 2-Chloro-n-(4-chloro-3-nitrophenyl)acetamide | AA00ACRQ | MFCD00157377
155628-02-7 | Ethanone, 2,2,2-trifluoro-1-[3-(1-methylethyl)phenyl]- (9CI) | AA00ACWV | MFCD06201806
159308-03-9 | 4,6-DiMethoxy-β-Methyl-3-phenoxy AMbrisentan | AA00AD41 | MFCD31562982
146794-70-9 | (6R-trans)-7-[(2,2-diMethyl-1-oxopropyl)aMino]-3-Methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2- | AA00ADB8 | MFCD28143294
1764-85-8 | Flurese | AA00ADI7 | MFCD00865893
19522-39-5 | Nsc92153 | AA00ADQD
161740-69-8 | Triamcinolone acetonide 21-aldehyde hydrate | AA00ADXI
152764-26-6 | 6-HydroxyMethyl ExeMestane | AA00AE4U | MFCD31562949
133123-69-0 | 1-Isopropyl-1H-imidazole-4,5-dicarbonitrile | AA00AHCM | MFCD18808570